Integral Health Asset Management, LLC Bristol Myers Squibb CO Transaction History

Integral Health Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $3.1 Million - $3.37 Million	-50,000 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $2.97 Million - $3.34 Million	50,000 New	50,000 $3.16 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $2.89 Million - $3.27 Million	-50,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $8.61 Million - $9.55 Million	-150,000 Reduced 75.0%	50,000 $3.02 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.37 Million - $1.6 Million	25,000 Added 14.29%	200,000 $11.8 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $696,000 - $1.01 Million	-15,000 Reduced 7.89%	175,000 $9.76 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $9.35 Million - $12.2 Million	190,000 New	190,000 $12.2 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.